Psoriasis Treatment Center Of Central New Jersey

This study looked at whether a drug called tralokinumab could help adults with eczema who had already tried dupilumab and didn't get enough relief. The plan was to treat 20 people for 24 weeks, but the study was stopped early and only 7 people took part. The main goal was to see …

This study tested the drug upadacitinib in 5 adults with moderate-to-severe prurigo nodularis, a condition causing very itchy skin bumps. The main goal was to see if it reduces itching by at least 4 points on a scale after 12 weeks. The study was stopped early, so results are lim…